SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-24-018922
Filing Date
2024-05-31
Accepted
2024-05-31 16:43:25
Documents
15
Period of Report
2024-03-25
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A nby20240531_8ka.htm   iXBRL 8-K/A 32435
2 EXHIBIT 99.1 ex_682007.htm EX-99.1 412994
  Complete submission text file 0001437749-24-018922.txt   604932

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nby-20240325.xsd EX-101.SCH 3401
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240325_def.xml EX-101.DEF 12172
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240325_lab.xml EX-101.LAB 16369
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240325_pre.xml EX-101.PRE 12442
18 EXTRACTED XBRL INSTANCE DOCUMENT nby20240531_8ka_htm.xml XML 3102
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33678 | Film No.: 241010439
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)